| Page 1551 | Kisaco Research
 

Michael Higgins

Managing Director, Biopharmaceuticals Equity Research
Ladenburg Thalmann & Co. Inc.

Michael Higgins

Managing Director, Biopharmaceuticals Equity Research
Ladenburg Thalmann & Co. Inc.

Michael Higgins

Managing Director, Biopharmaceuticals Equity Research
Ladenburg Thalmann & Co. Inc.
 

Dr Richard Alm

Director of Alliances
CARB-X / Consultant, WHO

Richard joined CARB-X as an Alliance Director following almost 20 years in large pharma Infection R&D teams followed by 4 years at a small antibacterial biotech company.  He has supported the progression of small molecule compounds from discovery through to late-stage clinical development.  He obtained his PhD in molecular microbiology from the University of Adelaide, and prior to joining industry he held two post-doctoral positions in the AMR area, one in Australia and one in Canada.

Dr Richard Alm

Director of Alliances
CARB-X / Consultant, WHO

Dr Richard Alm

Director of Alliances
CARB-X / Consultant, WHO

Richard joined CARB-X as an Alliance Director following almost 20 years in large pharma Infection R&D teams followed by 4 years at a small antibacterial biotech company.  He has supported the progression of small molecule compounds from discovery through to late-stage clinical development.  He obtained his PhD in molecular microbiology from the University of Adelaide, and prior to joining industry he held two post-doctoral positions in the AMR area, one in Australia and one in Canada. Richard is also a consultant on the Global Action Plan on Antimicrobial Resistance for the World Health Organization (WHO).

 

Rima Raouda

Tech Researcher & Content Director
Independent

Rima Raouda

Tech Researcher & Content Director
Independent

Rima Raouda

Tech Researcher & Content Director
Independent
 
BEAUTY & WELLNESS CONNECT EUROPE 2021
3-4 Mar 2021
VIRTUAL SUMMIT | GMT & EST Timezone
Connecting to customers authentically, having inclusivity and sustainability be part of your brand’s DNA, and finding the right retail and distribution partners have been critical for a while. The current dramatically different trading conditions have introduced new, urgent challenges: bringing your full brand experience online and innovation in the D2C model, as well as the uptick in skincare and haircare. The convergence of Beauty & Wellness presents opportunities: beauty is now about feeling good, as well as looking good.Indie and global brands, together with online and brick and mortar retail will share the lessons they have learned and what they’re focused on for the short-term future. As ever, the Beauty Spotlight will showcase some of the most exciting upcoming indie brands in Europe. We are excited and proud that so many brands we’ve featured are now on the shelves of major retailers and receiving investment. There’s still an enormous amount of interest in the next big brand from the investment community……is it yours?
 

Davis Sawyer

Co-Founder and CPO
Deeplite

Davis Sawyer

Co-Founder and CPO
Deeplite

Davis Sawyer

Co-Founder and CPO
Deeplite
Top 5 Issues for Start-Ups with Paul Dick & Associates
 
Women's Health Innovation Series: Contraception Summit
23 Feb 2021
VIRTUAL SUMMIT | PDT Timezone
Women’s health today is under-served from innovation and clinical science standpoints with outdated practices and lack of much-needed attention from key players (incl. investors and insurers). It is imperative to develop the eco-system, shift mindsets and embrace the holistic women-centred approach.As part of our leading Women’s Health Innovation Series, The Contraception Innovation Summit is the first instalment of our 1-day themed events throughout 2021. Take a deep-dive into the verticals that are driving change in women’s health to improve the quality and access to healthcare for women globally. Innovation in the contraception industry is long overdue. Women's desire to take ownership over their birth control, demanding more choice, safety, efficacy and education has become a vehicle for innovation and investment in this space.The Contraception Summit is about putting women at the centre of contraceptive research, innovations, and education to improve women’s contraceptive journeys throughout their lives. Join our leading network of pharma, biotech, medical device companies, start-ups, investors, researchers, and HCPs to drive innovation at the convergence of healthcare and technology.